Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Patent CN111995620A reveals a KHSO4-catalyzed route for 1,3,4-thiadiazoles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101274923B reveals a novel nitrate-catalyzed method for selective acylation, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103709212A reveals a novel three-step synthesis improving purity and yield. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103694288A reveals a novel three-step route for high-purity pharmaceutical intermediates. This method ensures cost reduction and supply chain reliability.
Advanced Lewis acid-catalyzed synthesis of Ezetimibe intermediates offers high purity and mild conditions, ensuring cost-effective supply for cardiovascular drug manufacturing.
Novel acidolysis process for acemetacin ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN112608359A introduces a continuous tubular reactor method for producing high-purity steroid intermediates, offering significant cost reduction and supply chain stability.
Patent CN111187264A introduces a resin-catalyzed cyclization for mirtazapine, eliminating sulfuric acid waste and simplifying purification for reliable pharmaceutical intermediate supply.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.
Patent CN105111073A details a high-yield synthesis for Higher Alkanol Gallate. Discover cost-effective production and supply chain advantages for food additives.
Patent CN113195454A reveals a novel synthesis route for Formula VI intermediates, offering superior purity over 99% and safer Lewis acid demethylation for scalable API manufacturing.
Patent CN111072734A reveals a high-yield route to Doxifluridine using a styryl-benzoate ribose donor, offering mild conditions and 98% coupling efficiency for API manufacturing.
Patent CN117700410B reveals a high-yield synthesis for Paliperidone intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Metal-free Brønsted acid catalyzed synthesis of trans-3,4-diaryl dihydrocoumarins with high diastereoselectivity. Ideal for scalable API intermediate manufacturing.
Novel patent CN105646137B offers cost-effective posaconazole intermediate synthesis without Grignard reagents, ensuring supply chain stability.
Novel hydrobromic acid catalyzed route ensures high purity and yield. Reduces processing time and cost for pharmaceutical intermediates manufacturing supply chain.
Patent CN102584905B details a novel Blanc chloromethylation method. This report analyzes cost reduction in pharma intermediates manufacturing and supply chain reliability for global buyers.
Novel solid superacid catalysis method for Tinidazole reduces waste and enhances purity for reliable pharmaceutical intermediate supply chains.
Patent CN114591278A details a novel ethylene carbonate cyclization method for prucalopride intermediates, offering high purity, safety, and cost reduction in API manufacturing.